Developer docs
API playgroundTry for free, no card

Search company profiles

European Hematology Association

Full company profile

uuid000exzh

Namestring
European Hematology Association
Legal namestring
European Hematology Association
Websiteurl
ehaweb.org
Company typeenum
Private
Founded yearint
1992
Descriptiontext

The European Hematology Association (EHA) is a private non-profit professional association headquartered in The Hague, Netherlands, founded circa 1995, serving hematology professionals across 150+ countries with 10,000+ members. The organization delivers a comprehensive portfolio centered on flagship annual congresses (EHA2025 Milan, EHA2026 Stockholm, EHA2027 Barcelona), the HemaSphere open-access peer-reviewed journal (preliminary 2025 Impact Factor of 11.3, ranked #8 globally and published in partnership with Wiley), and the European Hematology Curriculum endorsed by 27 national societies. Supporting products include the EHA Campus e-learning platform (250+ resources), EHA Guidelines mobile app, EHA Diagnosis reference tool, the European Hematology Exam and Progress Test, Mentorship Program, Master Class, Research Training Programs, and the EHA-EMBO Lab Leadership Course.

EHA generates revenue primarily through tiered membership subscriptions (Full €155, Junior €20, Healthcare-affiliated €90, Emeritus €90 annually), annual congress registration and sponsorship, the European Hematology Exam (€50–250 by format and membership status), EHA Campus access (membership-gated), and unrestricted educational grants from pharmaceutical sponsors including Johnson & Johnson and AstraZeneca. Its go-to-market is community-led and event-driven, leveraging 25 Specialized Working Groups, joint membership agreements with 16+ national hematology societies, and a MyEHA membership platform. The customer base spans hematologists, clinical researchers, early-career professionals, medical students, lab specialists, and healthcare-affiliated professionals. EHA's strategic positioning emphasizes 'borderless hematology' — standardizing training, guidelines, and research collaboration across Europe and beyond, supported by 26 published clinical practice guidelines and an active grants program.

Short descriptiontext

The European Hematology Association (EHA) is a Netherlands-based non-profit professional association serving 10,000+ hematology professionals across 150+ countries through annual congresses, the HemaSphere journal, educational programs, clinical guidelines, and certification exams.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersThe Hague, Netherlands
HQ citystring
The Hague
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hematology education, medical professional association, clinical practice guidelines, continuing medical education, medical research grants
Industry2 codes
1BPAHAJAL
CodeBPAHAJALPrimaryNo
2EDAGAGAJ
CodeEDAGAGAJPrimaryNo
NAICS code1 code
  • 81399
SIC code2 codes
  • 8600
  • 8000
Product category
Medical Professional Association / Hematology Education and Research
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Membership Fees
TypeSubscription Recurring
Description

Annual membership fees from multiple tiers: Full membership (€75 mid-year/€155 full), Junior membership (€20), Healthcare-affiliated professional (€45 mid-year), Emeritus membership (€45 mid-year). Includes discounted publishing fees for HemaSphere journal.

ehaweb.org
2European Hematology Exam Fees
TypeOne Time License
Description

Revenue from exam registration fees: €50-100 for LMIC candidates, €100-200 for on-site members, €150-250 for remote/online proctored exams. Includes VAT.

ehaweb.org
3EHA Campus Access
TypeSubscription Recurring
Description

EHA Campus courses require membership for access. EBAH accreditation available for completed courses. Some premium content and programs like Master Class require separate enrollment.

ehaweb.org
4Guidelines Endorsement Services
TypeLicensing Royalties
Description

EHA endorses clinical practice guidelines produced by partner societies (ESMO, BSH, ISTH, EAHAD, ISA, EuroBloodNet, EuNet-INNOCHRON) and processes endorsement requests on a case-by-case basis.

ehaweb.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details6 tiers
1Full membership for established researchers and physicians aged 37-64
ModelSubscriptionBilling cadenceAnnual
Notes

€75 mid-year (second half of 2026), regular €155. Includes access to EHA Campus, grants, mentorship programs, and discounted publishing in HemaSphere.

ehaweb.org
2Junior membership for early career professionals aged 36 or under
ModelSubscriptionBilling cadenceAnnual
Notes

€20 per year. Includes connection opportunities, early career opportunities, and eligibility for Congress travel grants.

ehaweb.org
3Healthcare-affiliated professional membership for lab specialists, nurses, technicians aged 37-64
ModelSubscriptionBilling cadenceAnnual
Notes

€45 mid-year (second half of 2026), regular €90. Not eligible to vote in EHA ballot.

ehaweb.org
4Emeritus membership for retired professionals aged 65 or over
ModelSubscriptionBilling cadenceAnnual
Notes

€45 mid-year (second half of 2026), regular €90. Enables continued connection and knowledge sharing.

ehaweb.org
5European Hematology Exam fees by format and membership status
ModelUnit PricingBilling cadencePay-as-you-go
Notes

LMIC Member: €50, LMIC Non-Member: €100. On-site Member: €100, On-site Non-Member: €200. Remote/Online Member: €150, Remote/Online Non-Member: €250. All fees include VAT.

ehaweb.org
660-day trial membership for prospective members
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free access for 60 days to select EHA Campus courses and European Hematology Curriculum. No existing or former EHA member/guest eligibility.

ehaweb.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1EHA Campus
Description

Online learning platform with over 250 learning resources including training programs, expert podcasts, and clinical cases.

ehaweb.org
+3 more records
Core offering1 text field

The European Hematology Association (EHA) is a non-profit professional association founded in 1994/1995 and headquartered in The Hague, Netherlands, dedicated to supporting hematologists and healthcare professionals in blood diseases. EHA's core offerings include the annual EHA Congress, the open-access HemaSphere journal, the EHA Campus e-learning platform, the European Hematology Exam certification, mentorship programs, clinical practice guidelines, and research grants.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 78% of Progress Test takers passed the European Hematology Exam
+2 more records
Product overview1 text field

The European Hematology Association (EHA) operates as a professional medical association offering a comprehensive ecosystem of products and services for hematology professionals. The portfolio centers on annual Congresses (EHA2026 in Stockholm, EHA2027 in Barcelona), the HemaSphere open-access journal (Impact Factor 11.3), and the EHA Campus online learning platform (250+ resources). Educational offerings include certification via EHA Exam and Progress Test, career development through Mentorship Program and Master Class, and specialized training via Research Training Programs and the EHA-EMBO Lab Leadership Course. Clinical support tools include EHA Diagnosis (diagnostic reference with images), EHA Guidelines App (mobile access to guidelines), Bedside Hematology Rapid Reference (emergency resource), and 36 published/endorsed Clinical Practice Guidelines. The association supports research through grants and 25 Specialized Working Groups. The MyEHA platform serves as the membership management hub with joint membership options across 16 national societies. All offerings are connected through the European Hematology Curriculum framework and delivered via the MyEHA platform ecosystem.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
1Albanian Association of Hematology (AAH)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership enabling Albanian hematologists to access both national and European hematology networks through single registration. Part of EHA's borderless hematology initiative to expand reach across European nations.

ehaweb.org
2Armenian Hematology Association (AHA)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership facilitating Armenian hematology professionals' access to EHA resources, congresses, and European research networks.

ehaweb.org
3Bulgarian Medical Society of Hematology (BMSH)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership enabling Bulgarian hematologists to engage with both national and pan-European hematology community through combined membership benefits.

ehaweb.org
4Société Française d'Hématologie (SFH)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership with French national hematology society, facilitating cross-border professional development and research collaboration.

ehaweb.org
5British Society of Haematology (BSH)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership with UK hematology society, providing British hematologists integrated access to European hematology resources and BSH professional networks.

ehaweb.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative guideline development partnership. EHA endorses ESMO clinical practice guidelines for various hematologic malignancies including Waldenström's macroglobulinemia, marginal zone lymphomas, follicular lymphoma, and mantle cell lymphoma.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration on clinical practice guideline development for hematologic diseases. EuroBloodNet provides European reference network expertise for rare hematological diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint guideline development partnership including the EHA-ISTH-EAHAD-ESO Clinical Practice Guidance for Antithrombotic Treatment in Patients With Hemophilia.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative guideline development for bleeding and thrombotic disorders. Co-authors EHA-ISTH-EAHAD-ESO clinical practice guidance documents.

10International Society of Amyloidosis (ISA)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Guideline endorsement partnership for AL amyloidosis guidelines. EHA endorses ISA-developed clinical practice guidelines in this area.

ehaweb.org
Strategic tierCoreTypeTechnology or Integration
Description

Publishing partner for HemaSphere journal. Wiley provides digital and physical publishing platforms enabling global reach of EHA's open-access hematology journal.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint development of EHA-SIOPe Pediatric Extended Syllabus, an addendum to the adult hematology curriculum covering pediatric hematology topics.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership for EHA-EMBO Lab Leadership Course, providing leadership training for early-career researchers transitioning into independent research group leadership roles.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaborative guideline development partnership for chronic myelomonocytic leukemia and other myeloproliferative neoplasms.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

Independent psychometric evaluation partner for European Hematology Exam. Provides quality assurance through expert analysis of exam reliability, item quality using Rit/Rir correlations, and passing score definition.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

Congress Secretariat handling EHA Congress logistics including registration, abstract management, hotel accommodation, and general congress enquiries.

17Swiss Society of Hematology (SSH)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership with Swiss national hematology society for integrated professional access.

ehaweb.org
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Joint membership partnership with Spanish national hematology society facilitating cross-border professional connectivity.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

European Hematology Association

Medical Professional Association / Hematology Education and Researchehaweb.org

The European Hematology Association (EHA) is a Netherlands-based non-profit professional association serving 10,000+ hematology professionals across 150+ countries through annual congresses, the HemaSphere journal, educational programs, clinical guidelines, and certification exams.

What European Hematology Association does

The European Hematology Association (EHA) is a private non-profit professional association headquartered in The Hague, Netherlands, founded circa 1995, serving hematology professionals across 150+ countries with 10,000+ members. The organization delivers a comprehensive portfolio centered on flagship annual congresses (EHA2025 Milan, EHA2026 Stockholm, EHA2027 Barcelona), the HemaSphere open-access peer-reviewed journal (preliminary 2025 Impact Factor of 11.3, ranked #8 globally and published in partnership with Wiley), and the European Hematology Curriculum endorsed by 27 national societies. Supporting products include the EHA Campus e-learning platform (250+ resources), EHA Guidelines mobile app, EHA Diagnosis reference tool, the European Hematology Exam and Progress Test, Mentorship Program, Master Class, Research Training Programs, and the EHA-EMBO Lab Leadership Course.

EHA generates revenue primarily through tiered membership subscriptions (Full €155, Junior €20, Healthcare-affiliated €90, Emeritus €90 annually), annual congress registration and sponsorship, the European Hematology Exam (€50–250 by format and membership status), EHA Campus access (membership-gated), and unrestricted educational grants from pharmaceutical sponsors including Johnson & Johnson and AstraZeneca. Its go-to-market is community-led and event-driven, leveraging 25 Specialized Working Groups, joint membership agreements with 16+ national hematology societies, and a MyEHA membership platform. The customer base spans hematologists, clinical researchers, early-career professionals, medical students, lab specialists, and healthcare-affiliated professionals. EHA's strategic positioning emphasizes 'borderless hematology' — standardizing training, guidelines, and research collaboration across Europe and beyond, supported by 26 published clinical practice guidelines and an active grants program.

European Hematology Association firmographics

Firmographics
Name
European Hematology Association
Legal name
European Hematology Association
Website
https://ehaweb.org
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
51–100 employees
Short description
The European Hematology Association (EHA) is a Netherlands-based non-profit professional association serving 10,000+ hematology professionals across 150+ countries through annual congresses, the HemaSphere journal, educational programs, clinical guidelines, and certification exams.
Ownership category
akta.pro rank

Where European Hematology Association is headquartered

Location

Headquarters

HQ city
The Hague
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

European Hematology Association business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Membership Fees: Annual membership fees from multiple tiers: Full membership (€75 mid-year/€155 full), Junior membership (€20), Healthcare-affiliated professional (€45 mid-year), Emeritus membership (€45 mid-year). Includes discounted publishing fees for HemaSphere journal.
  2. European Hematology Exam Fees: Revenue from exam registration fees: €50-100 for LMIC candidates, €100-200 for on-site members, €150-250 for remote/online proctored exams. Includes VAT.
  3. EHA Campus Access: EHA Campus courses require membership for access. EBAH accreditation available for completed courses. Some premium content and programs like Master Class require separate enrollment.
  4. Guidelines Endorsement Services: EHA endorses clinical practice guidelines produced by partner societies (ESMO, BSH, ISTH, EAHAD, ISA, EuroBloodNet, EuNet-INNOCHRON) and processes endorsement requests on a case-by-case basis.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualFull membership for established researchers and physicians aged 37-64
SubscriptionAnnualJunior membership for early career professionals aged 36 or under
SubscriptionAnnualHealthcare-affiliated professional membership for lab specialists, nurses, technicians aged 37-64
SubscriptionAnnualEmeritus membership for retired professionals aged 65 or over
Unit PricingPay-as-you-goEuropean Hematology Exam fees by format and membership status
FreemiumPay-as-you-go60-day trial membership for prospective members

Go-to-market motion2 records

Distribution channels7 records

Marketing channels9 records

European Hematology Association product offering

Product offering

Core offering

The European Hematology Association (EHA) is a non-profit professional association founded in 1994/1995 and headquartered in The Hague, Netherlands, dedicated to supporting hematologists and healthcare professionals in blood diseases. EHA's core offerings include the annual EHA Congress, the open-access HemaSphere journal, the EHA Campus e-learning platform, the European Hematology Exam certification, mentorship programs, clinical practice guidelines, and research grants.

Product overview

The European Hematology Association (EHA) operates as a professional medical association offering a comprehensive ecosystem of products and services for hematology professionals. The portfolio centers on annual Congresses (EHA2026 in Stockholm, EHA2027 in Barcelona), the HemaSphere open-access journal (Impact Factor 11.3), and the EHA Campus online learning platform (250+ resources). Educational offerings include certification via EHA Exam and Progress Test, career development through Mentorship Program and Master Class, and specialized training via Research Training Programs and the EHA-EMBO Lab Leadership Course. Clinical support tools include EHA Diagnosis (diagnostic reference with images), EHA Guidelines App (mobile access to guidelines), Bedside Hematology Rapid Reference (emergency resource), and 36 published/endorsed Clinical Practice Guidelines. The association supports research through grants and 25 Specialized Working Groups. The MyEHA platform serves as the membership management hub with joint membership options across 16 national societies. All offerings are connected through the European Hematology Curriculum framework and delivered via the MyEHA platform ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

  • EHA Campus: Online learning platform with over 250 learning resources including training programs, expert podcasts, and clinical cases.
  • EHA Diagnosis
  • HemaSphere
  • Lighting the Flame Program

Quantifiable outcome

  • 78% of Progress Test takers passed the European Hematology Exam
  • +2 more outcomes

Companies that use European Hematology Association

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

European Hematology Association technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

European Hematology Association partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered core and major.

  • Albanian Association of Hematology (AAH)coreChannel Partner/ Reseller/ DistributorJoint membership partnership enabling Albanian hematologists to access both national and European hematology networks through single registration. Part of EHA's borderless hematology initiative to expand reach across European nations.
  • Armenian Hematology Association (AHA)coreChannel Partner/ Reseller/ DistributorJoint membership partnership facilitating Armenian hematology professionals' access to EHA resources, congresses, and European research networks.
  • Bulgarian Medical Society of Hematology (BMSH)coreChannel Partner/ Reseller/ DistributorJoint membership enabling Bulgarian hematologists to engage with both national and pan-European hematology community through combined membership benefits.
  • Société Française d'Hématologie (SFH)coreChannel Partner/ Reseller/ DistributorJoint membership partnership with French national hematology society, facilitating cross-border professional development and research collaboration.
  • British Society of Haematology (BSH)coreChannel Partner/ Reseller/ DistributorJoint membership partnership with UK hematology society, providing British hematologists integrated access to European hematology resources and BSH professional networks.
  • European Society for Medical Oncology (ESMO)coreStrategic or Co-development PartnerCollaborative guideline development partnership. EHA endorses ESMO clinical practice guidelines for various hematologic malignancies including Waldenström's macroglobulinemia, marginal zone lymphomas, follicular lymphoma, and mantle cell lymphoma.
  • EuroBloodNetmajorStrategic or Co-development PartnerCollaboration on clinical practice guideline development for hematologic diseases. EuroBloodNet provides European reference network expertise for rare hematological diseases.
  • International Society on Thrombosis and Haemostasis (ISTH)coreStrategic or Co-development PartnerJoint guideline development partnership including the EHA-ISTH-EAHAD-ESO Clinical Practice Guidance for Antithrombotic Treatment in Patients With Hemophilia.
  • European Association for Haemophilia and Allied Disorders (EAHAD)coreStrategic or Co-development PartnerCollaborative guideline development for bleeding and thrombotic disorders. Co-authors EHA-ISTH-EAHAD-ESO clinical practice guidance documents.
  • International Society of Amyloidosis (ISA)majorStrategic or Co-development PartnerGuideline endorsement partnership for AL amyloidosis guidelines. EHA endorses ISA-developed clinical practice guidelines in this area.
  • WileycoreTechnology or IntegrationPublishing partner for HemaSphere journal. Wiley provides digital and physical publishing platforms enabling global reach of EHA's open-access hematology journal.
  • European Society for Paediatric Oncology (SIOPe)majorStrategic or Co-development PartnerJoint development of EHA-SIOPe Pediatric Extended Syllabus, an addendum to the adult hematology curriculum covering pediatric hematology topics.
  • EMBOmajorStrategic or Co-development PartnerPartnership for EHA-EMBO Lab Leadership Course, providing leadership training for early-career researchers transitioning into independent research group leadership roles.
  • EuNet-INNOCHRONmajorStrategic or Co-development PartnerCollaborative guideline development partnership for chronic myelomonocytic leukemia and other myeloproliferative neoplasms.
  • CitomajorImplementation/ SI/ Consulting PartnerIndependent psychometric evaluation partner for European Hematology Exam. Provides quality assurance through expert analysis of exam reliability, item quality using Rit/Rir correlations, and passing score definition.
  • INTERPLAN CongressmajorImplementation/ SI/ Consulting PartnerCongress Secretariat handling EHA Congress logistics including registration, abstract management, hotel accommodation, and general congress enquiries.
  • Swiss Society of Hematology (SSH)coreChannel Partner/ Reseller/ DistributorJoint membership partnership with Swiss national hematology society for integrated professional access.
  • Sociedad Española de Hematología y Hemoterapia (SEHH)coreChannel Partner/ Reseller/ DistributorJoint membership partnership with Spanish national hematology society facilitating cross-border professional connectivity.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

European Hematology Association competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat6 records

Customer concentration

European Hematology Association social profiles

Digital presence

European Hematology Association financial estimates

Financial estimate

Revenue estimate

Valuation estimate

European Hematology Association leadership team

Management profile

Number of profiles

European Hematology Association funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

European Hematology Association M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Hematology Association

What does European Hematology Association do?

The European Hematology Association (EHA) is a non-profit professional association founded in 1994/1995 and headquartered in The Hague, Netherlands, dedicated to supporting hematologists and healthcare professionals in blood diseases. EHA's core offerings include the annual EHA Congress, the open-access HemaSphere journal, the EHA Campus e-learning platform, the European Hematology Exam certification, mentorship programs, clinical practice guidelines, and research grants.

Is European Hematology Association a public or private company?

European Hematology Association is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was European Hematology Association founded?

European Hematology Association was founded in 1992. It employs 51 to 100 people.

Where is European Hematology Association based?

European Hematology Association is headquartered in The Hague, Netherlands, in the Europe region.

How does European Hematology Association make money?

Four revenue lines are on record. Membership Fees are the primary driver. The others are european Hematology Exam Fees, EHA Campus Access and guidelines Endorsement Services.

Does European Hematology Association have an API?

No public API is recorded for European Hematology Association.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AJMCEHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across HematologyThe European Hematology Association (EHA) 2026 Congress featured six late-breaking abstracts presenting significant clinical trial data for hematologic diseases, including positive phase 3 results for pirtobrutinib combinations and mezigdomide. Additionally, early-phase trials demonstrated promising potential for novel CAR T-cell therapies in treating B-cell non-Hodgkin lymphoma and autoimmune conditions like primary immune thrombocytopenia.PR NewswireKaryopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026Karyopharm Therapeutics announced that its Phase 3 SENTRY trial evaluating selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis patients was selected for a late-breaking oral presentation at the 2026 European Hematology Association Congress in Stockholm. The presentation will highlight post-hoc analysis indicating that achieving spleen volume reduction of 35% or more (SVR35) may predict overall survival, along with data showing rapid, deep and sustained spleen volume reductions with a manageable safety profile. The abstract was selected as one of the six best abstracts for the Late-Breaking Oral Session on June 14, 2026.BioSpaceClimb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 CongressClimb Bio will present budoprutug data at the EHA 2026 Congress in Stockholm, including safety, B-cell depletion, and initial platelet data from a low-dose cohort. The data comes from the Phase 1b/2a trial in previously treated primary immune thrombocytopenia patients.BioSpaceIncyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 CongressIncyte announced that data from its Hematology and Oncology programs will be presented at the EHA 2026 Congress in Stockholm, June 11-14, 2026. The presentations include the frontMIND Phase 3 trial for tafasitamab in DLBCL and multiple studies for INCA033989 in myeloproliferative neoplasms.NatureEHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myelomaThe European Hematology Association (EHA) and European Myeloma Network (EMN) have updated their evidence-based clinical practice guidelines for the diagnosis, treatment, and follow-up of multiple myeloma. The update incorporates 14 novel regimens approved by the EMA and FDA since 2021, new prognostic factors such as minimal residual disease assessment, and refined algorithms for managing smouldering and relapsed/refractory disease. Key recommendations include the use of quadruplet induction therapies like daratumumab combined with VRd or IsaVRd for newly diagnosed patients and specific immunotherapies like cilta-cel and belantamab mafodotin for relapsed cases.GlobeNewswireNurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association CongrNurix Therapeutics will host a webcast conference call on June 12, 2025, to discuss new data from its Phase 1 clinical trial of bexobrutideg (NX-5948) to be presented at the European Hematology Association Congress in Milan. The data covers relapsed refractory CLL and Waldenström macroglobulinemia, with the call at 8:00 a.m. ET.GlobeNewswireDisc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 CongressDisc Medicine will present data from its hematology portfolio at the EHA 2025 Congress in Milan, including bitopertin, DISC-0974, and DISC-3405. The company will host a corporate update call on June 16 to review the presented data.GlobeNewswireNurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant LymphomaNurix Therapeutics announced that data from its Phase 1a/b trial of bexobrutideg in relapsed/refractory CLL and Waldenström macroglobulinemia will be presented at EHA 2025 and ICML 2025. The data will be featured in posters and an oral presentation, with the trial ongoing.PR NewswireEHA: avanzando en el campo de la hematologíaThe European Hematology Association (EHA) has undergone a notable transformation over the past two years, achieving a 17% membership increase in 2024 to 7,972 members from over 152 countries, while its scientific journal HemaSphere reached a record impact factor of 12.1 in 2023. The EHA2024 Congress in Madrid drew 14,000 in-person attendees and 17,900 total registrations with 3,500 abstracts presented, marking an unprecedented milestone for the organization. EHA is now unveiling a new brand identity to reflect its evolution as a global network connecting hematology professionals worldwide.GlobeNewswireNurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024)Nurix Therapeutics will host a webcast and conference call on June 16, 2024, to present updated data from its Phase 1a/b trial of NX-5948 in relapsed/refractory CLL and non-Hodgkin lymphoma. The oral presentation at EHA2024 will cover patients with BTK inhibitor resistance mutations and CNS involvement.